Term responses to TKIs or any other therapeutic option1-6. The
Term responses to TKIs or any other therapeutic option1-6. The molecular mechanisms responsible for blastic transformation and drug-resistance in CML-BC are nonetheless unclear but most likely involve each BCR-ABL1 kinase-dependent…